Author:
She Qing-Bai,Gruvberger-Saal Sofia K.,Maurer Matthew,Chen Yilun,Jumppanen Mervi,Su Tao,Dendy Meaghan,Lau Ying-Ka Ingar,Memeo Lorenzo,Horlings Hugo M.,van de Vijver Marc J.,Isola Jorma,Hibshoosh Hanina,Rosen Neal,Parsons Ramon,Saal Lao H.
Funder
National Institutes of Health
Stand Up to Cancer
Avon Foundation for Women
Cancerfonden
Vetenskapsrådet
Fru Berta Kamprads Stiftelse
Skåne University Hospital Foundation
King Gustav V’s Jubilee Foundation
Krapperup Foundation
Gunnar Nilsson Cancer Foundation
Crafoordska Stiftelsen
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference56 articles.
1. Rakha E, Reis-Filho JS. Basal-like breast carcinoma: from expression profiling to routine practice. Arch Pathol Lab Med. 2009;133(6):860–8.
2. Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmstrom PO, Mansukhani M, Enoksson J, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005;65(7):2554–9.
3. Li SY, Rong M, Grieu F, Iacopetta B. PIK3CA mutations in breast cancer are associated with poor outcome. Breast Cancer Res Treat. 2006;96(1):91–5.
4. Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res. 2008;68(15):6084–91.
5. Miron A, Varadi M, Carrasco D, Li H, Luongo L, Kim HJ, Park SY, Cho EY, Lewis G, Kehoe S, et al. PIK3CA mutations in in situ and invasive breast carcinomas. Cancer Res. 2010;70(14):5674–8.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献